Fatal adverse drug events: The paradox of drug treatment

Journal of Internal Medicine

Volumn 250, Issue 4, 2001, Pages 327-341

  Buajordet, I ^a   Ebbesen, J ^b   Erikssen, J ^b   Brors O ^c   Hilberg, T ^d  

^a Norwegian Medicines Agency   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d National Institute of Forensic Toxicology   (Norway)

Author keywords

Adverse drug events; Fatal; Internal medicine

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; ANTITHROMBOCYTIC AGENT; BIGUANIDE DERIVATIVE; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGITOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; HEPARIN; INSULIN; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STREPTOKINASE; TERBUTALINE SULFATE; THEOPHYLLINE; UNINDEXED DRUG; WARFARIN; XANTHINE;

ADULT; AGED; ARTICLE; AUTOPSY; CANCER PATIENT; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEATH; DOSE CALCULATION; DRUG ADMINISTRATION ROUTE; DRUG FATALITY; FEMALE; GASTROINTESTINAL DISEASE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; PATIENT CARE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DRUG INTERACTIONS; FEMALE; HUMANS; INTERNAL MEDICINE; MALE; MEDICATION ERRORS; MIDDLE AGED; NORWAY; PHARMACEUTICAL PREPARATIONS; RISK FACTORS;

EID: 0034797975     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00892.x     Document Type: Article

References (37)

1. Incidence of adverse drug events and potential adverse drug events. Implications for prevention
2. Systems analysis of adverse drug events
3. Relationship between medication errors and adverse drug events
4. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality
5. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
6. Frequency, reporting and classification of drug-related deaths
7. Drug related deaths in a Department of Internal Medicine
8. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients - A comment
9. Adverse drug reactions and death. A review of 827 cases
10. Drug consumption and adverse reactions in a Department of Internal Medicine
11. Drug-associated deaths of medical inpatients
12. Drug-related deaths among medical inpatients
13. Systematic analysis of inpatients' circumstances and causes of death: A tool to improve quality of care
14. Causal or causal? The role of causality assessment in pharmacovigilance
15. A comprehensive clinical epidemiological theory based on the concept of the source person-time and four distinct study stages
16. Deaths due to medical errors are exaggerated in Institute of Medicine report
17. Institute of Medicine medical error figures are not exaggerated
18. Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population
19. Effect of disease states on theophylline elimination
20. A comparison of drug interaction software programs: Applicability to the emergency department
21. Computerized surveillance of adverse drug reactions in hospital: Implementation
22. A computer alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital
23. Top-priority actions for preventing adverse drug events in hospitals. Recommendations of an expert panel
24. The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man
25. Arrhythmogenic effects of orally administered bronchodilators
26. Regional distribution of beta-adrenoceptors in the human heart: Coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy
27. Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study
28. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants
29. Bronchodilators and acute cardiac death
30. Arrhythmogenicity from combined bronchodilator therapy in patients with obstructive lung disease and concomitant ischemic heart disease
31. The risk of myocardial infarction associated with antihypertensive drug therapies
32. The risk for and severity of bleeding complications in elderly patients treated with warfarin
33. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
34. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events